INDIANAPOLIS and MONTREAL, Oct. 12, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S.

PENZBERG, Germany, June 14, 2011 /PRNewswire/ -- At the "Developments in Real-Time PCR" Symposium in Prague, June 13th - 17thhttp://www.qpcrsymposium.eu/ , Roche (SIX: RO, ROG; OTCQX: RHHBY [http://www.roche.com/investors.htm ]) officially presented the latest addition to the company's real-time PCR portfolio of LightCycler(R) instruments.

YORKTOWN HEIGHTS, N.Y. and BRANFORD, Conn., July 1 /PRNewswire-FirstCall/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and IBM (NYSE: IBM) announced today an agreement to develop a nanopore-based technology that will directly read and sequence human DNA quickly and efficiently.

Using the Genome Sequencer System from 454 Life Sciences, a Roche company, French scientists have identified a small virus that can actually be parasitic to a larger one.

Using the Genome Sequencer FLX system from 454 Life Sciences, a Roche company, investigators have identified a number of genetic variations potentially linked to prostate, breast, and colon cancers within a previously identified region of the human genome called 8q24.